Open original FDA record ↗Recall record
- FDA identifier
- Z-1276-2018
- Company in FDA record
- Phadia Ab
- FDA record creation date
- Mar 30, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
We want to inform all Phadia 250 system operators performing EliA Assays not to use the function OK to All in any version of Phadia Prime, up to and including 2.1.4, when rejecting and retesting samples with any EliA assay (the OK function may be used for rejecting single tests and dilution of samples in accordance with product DfU).
Source facts
- Action
- An urgent recall notification was issued to customers in November of 2017, and informs all Phadia 250 system operators performing EliA Assays not to use the function OK to All in any version of Phadia Prime, up to and including 2.1.4, when rejecting and retesting samples with any EliA assay (the OK function may be used for rejecting single tests and dilution of samples in accordance with product DfU). For further questions, please call (269) 492-1940.
- Initiated
- 2017-11-20
- Root cause
- Software design
- Terminated
- 2019-03-06
- Distribution
- US Distribution to the states of :TX, VA, NJ, MA, IN, GA, UT, TN, CA, MS, NC, ME and OR
- Recall number
- Z-1276-2018
- Recall status
- Terminated
- CDRH record ID
- 162329
- FDA record created
- 2018-03-30
- Recall event number
- 79438